id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-4433-0002,FDA,FDA-2019-D-4433,Development of Locally Applied Corticosteroid Products for the Short-Term Treatment of Symptoms Associated with Internal or External Hemorrhoids Guidance for Industry DRAFT GUIDANCE,Other,Guidance,2019-12-09T05:00:00Z,2019,12,2019-12-09T05:00:00Z,,2024-11-12T23:13:30Z,,1,0,09000064841f69da
FDA-2019-D-4433-0001,FDA,FDA-2019-D-4433,Development of Locally Applied Corticosteroid Products for the Short- Term Treatment of Symptoms Associated With Internal or External Hemorrhoids; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2019-12-09T05:00:00Z,2019,12,2019-12-09T05:00:00Z,2020-02-08T04:59:59Z,2020-02-08T02:03:51Z,2019-26464,0,0,09000064841f6201